Gilead Sciences
GILD
NASDAQ
IPO1992
about GILD
Gilead Sciences develops innovative pharmaceuticals to treat conditions such as HIV/AIDS, hepatitis C, and other serious diseases.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $122.29 | $122.53 | $120.38 | $152.13B | 10.42M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| +$2.46 | 20.11 | 19.57 | 42.82% | 39.28% | 2.61% |